Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction

Abstract

Background

Hyponatremia is associated with an increased risk of mortality in patients with heart failure and in acute ST-segment elevation myocardial infarction (STEMI). The aim was to assess the impact of hyponatremia on admission on long-term mortality of patients with first ever STEMI or non-STEMI (NSTEMI).

Design

This was a longitudinal observation study

Methods

The study population consisted of 3558 patients, aged 25–74 years, with an incident acute myocardial infarction (AMI) in the years 2000–2008 who survived for at least 28 days. All consecutive patients were registered through the Cooperative Health Research in the Region of Augsburg (KORA) Myocardial Infarction Registry. Serum sodium levels were obtained on admission. The association with long-term-mortality was examined using Cox regression models.

Results

Hyponatraemia, defined as a sodium level less than 136 mmol/l, was present in 658 (18.5%) patients on admission. During a median follow-up period of six years (interquartile range (IQR) 4.0–8.2 years), 526 patients (14.8%) died. Hyponatraemia was significantly associated with long-term mortality by an 83% higher risk in the age- and sex-adjusted analysis. After further adjustment for reduced left ventricular ejection fraction (LVEF), glomerular filtration rate, haemoglobin, hypertension, hyperlipidaemia, any recanalization therapy, diabetes, medication with diuretics and angiotensin-converting enzyme (ACE) inhibitor/angiotensin-receptor blocker before admission and other parameters hyponatraemia remained a strong predictor for higher long-term mortality (hazard ratio 1.61; 95% confidence interval 1.32–1.97).

Conclusions

Patients with incident AMI and hyponatraemia on admission showed a significantly higher risk of long-term mortality than patients without. This strong predictive value was independent of a number of prognostic factors, including diabetes, glomerular filtration rate or reduced LVEF.

Keywords

Hyponatraemia myocardial infarction mortality Cooperative Health Research in the Region of Augsburg

Get full access to this article

View all access options for this article.

References

Ghali

. Mechanisms, risks, and new treatment options for hyponatremia. Cardiology 2008; 111: 147–157.

Goldberg

Hammerman

Petcherski

. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med 2004; 117: 242–248.

Lazzeri

Valente

Chiostri

. Usefulness of hyponatremia in the acute phase of ST-elevation myocardial infarction as a marker of severity. Am J Cardiol 2012; 110: 1419–1424.

Goldberg

Hammerman

Petcherski

. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 2006; 166: 781–786.

Diaconu

Balaccanu

Paraschiv

. Predictors of rehospitalization in chronic heart failure patients. Eur J Prev Cardiol 2014; 21: S52–S83.

Latini

Masson

Anand

. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004; 25: 292–299.

Palmer

Pilbrow

Frampton

. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. Eur Heart J 2008; 29: 2489–2496.

Schou

Valeur

Torp-Pedersen

. Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF. Eur J Clin Invest 2011; 41: 1237–1244.

Sahin

Asci

Kircelli

. The impact of low serum sodium level on mortality depends on glycemic control. Eur J Clin Invest 2012; 42: 534–540.

10.

Tang

Hua

. Relationship between hyponatremia and in-hospital outcomes in Chinese patients with ST-elevation myocardial infarction. Intern Med 2011; 50: 969–974.

11.

Tada

Nakamura

Funayama

. Early development of hyponatremia implicates short- and long-term outcomes in ST-elevation acute myocardial infarction. Circ J 2011; 75: 1927–1933.

12.

Klopotowski

Kruk

Przyluski

. Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: The ANIN Myocardial Infarction Registry. Med Sci Monit 2009; 15: CR477–CR483.

13.

Havranek

Belohlavek

Skulec

. Long-term prognostic impact of hyponatremia in the ST-elevation myocardial infarction. Scand J Clin Lab Invest 2011; 71: 38–44.

14.

Meisinger

Hörmann

Heier

. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol 2006; 113: 229–235.

15.

Kuch

Heier

von Scheidt

. 20-Year-trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram–results of the MONICA/KORA Augsburg Myocardial Infarction Registry (1985–2004). Am J Cardiol 2007; 100: 1056–1060.

16.

Wende

von Klot

Kirchberger

. The influence of lunar phases on the occurrence of myocardial infarction: Fact or myth? The MONICA/KORA Myocardial Infarction Registry. Eur J Prev Cardiol 2013; 20: 268–274.

17.

Qureshi

Hassan

Khalid

. Outcomes of correcting hyponatremia in patients with myocardial infarction. Clin Res Cardiol 2013; 102: 637–644.

18.

Dzau

Hollenberg

. Renal response to captopril in severe heart failure: Role of furosemide in natriuresis and reversal of hyponatremia. Ann Intern Med 1984; 100: 777–782.

19.

Dzau

. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987; 31: 1402–1415.

20.

Lilly

Dzau

Williams

. Hyponatremia in congestive heart failure: Implications for neurohormonal activation and responses to orthostasis. J Clin Endocrinol Metabol 1984; 59: 924–930.

21.

Klein

O'Conner

Leimberger

. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study. Circulation 2005; 111: 2454–2460.

22.

Singla

Zahid

Good

. Effect of hyponatremia (<135 mEQ/L) on outcome in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol 2007; 100: 406–408.

23.

Corona

Giuliani

Parenti

. Moderate hyponatremia is associated with increased risk of mortality: Evidence from a meta-analysis. PLoS One 2013; 8: e80451–e80451.

24.

Balling

Schou

Videbaek

. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail 2011; 13: 968–973.

25.

Rusinaru

Tribouilloy

Berry

. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: An individual patient data meta-analysis. Eur J Heart Fail 2012; 14: 1139–1146.

26.

Correia L, Ferreira R, Correia I, et al. Severe hyponatremia in older patients at admission in an internal medicine department. Arch Gerontol Geriatr. Epub ahead of print 12 August 2014. DOI: 10.1016/j.archger.2014.08.002.

27.

Hoorn

Zietse

. Hyponatremia and mortality: Moving beyond associations. Am J Kidney Dis 2013; 62: 139–149.

28.

Tzoulis

Bagkeris

Bouloux

. A case-control study of hyponatraemia as an independent risk factor for inpatient mortality. Clin Endocrinol 2014; 81: 401–407.

29.

Spasovski

Vanholder

Allolio

. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014; 29: ii1–ii39.

30.

Hori

. Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure. Future Cardiol 2013; 9: 163–176.

31.

Nemerovski

Hutchinson

. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: A clinical review. Clin Ther 2010; 32: 1015–1032.